DE69115526T2 - 2,4-Pyrimidindionderivate und diese enthaltende Arzneimittel - Google Patents
2,4-Pyrimidindionderivate und diese enthaltende ArzneimittelInfo
- Publication number
- DE69115526T2 DE69115526T2 DE69115526T DE69115526T DE69115526T2 DE 69115526 T2 DE69115526 T2 DE 69115526T2 DE 69115526 T DE69115526 T DE 69115526T DE 69115526 T DE69115526 T DE 69115526T DE 69115526 T2 DE69115526 T2 DE 69115526T2
- Authority
- DE
- Germany
- Prior art keywords
- medicaments containing
- denotes
- pyrimidinedione derivatives
- alkyl group
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR909003342A FR2659656B1 (fr) | 1990-03-15 | 1990-03-15 | Derives de pyrimidinedione-2,4 et medicaments les contenant. |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69115526D1 DE69115526D1 (de) | 1996-02-01 |
DE69115526T2 true DE69115526T2 (de) | 1996-06-05 |
Family
ID=9394780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69115526T Expired - Fee Related DE69115526T2 (de) | 1990-03-15 | 1991-03-14 | 2,4-Pyrimidindionderivate und diese enthaltende Arzneimittel |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0447324B1 (de) |
JP (1) | JP2983669B2 (de) |
AT (1) | ATE131817T1 (de) |
CA (1) | CA2038198A1 (de) |
DE (1) | DE69115526T2 (de) |
DK (1) | DK0447324T3 (de) |
ES (1) | ES2081446T3 (de) |
FR (1) | FR2659656B1 (de) |
GR (1) | GR3019123T3 (de) |
IE (1) | IE71192B1 (de) |
PT (1) | PT97035B (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU214331B (hu) * | 1992-06-17 | 1998-03-02 | Gyógyszerkutató Intézet Kft. | Eljárás piperazin- és homopiperazinszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására |
DE69430587T2 (de) * | 1994-02-28 | 2003-01-09 | Sunkyong Ind Ltd | Pyrimidin-acyclonukleosid-derivate |
JP3497554B2 (ja) * | 1994-03-25 | 2004-02-16 | 日本臓器製薬株式会社 | 新規プリン誘導体及びその薬学的に許容される塩 |
DE19702785A1 (de) * | 1997-01-27 | 1998-07-30 | Bayer Ag | Neue cyclische Harnstoffderivate |
US6417180B1 (en) * | 1998-10-07 | 2002-07-09 | University Of Massachusetts | Zinc finger-reactive antimicrobial compounds |
SE9903544D0 (sv) | 1999-10-01 | 1999-10-01 | Astra Pharma Prod | Novel compounds |
GB2359078A (en) | 2000-02-11 | 2001-08-15 | Astrazeneca Uk Ltd | Pharmaceutically active pyrimidine derivatives |
GB2359081A (en) | 2000-02-11 | 2001-08-15 | Astrazeneca Uk Ltd | Pharmaceutically active thiazolopyrimidines |
GB2359551A (en) * | 2000-02-23 | 2001-08-29 | Astrazeneca Uk Ltd | Pharmaceutically active pyrimidine derivatives |
SE0003828D0 (sv) | 2000-10-20 | 2000-10-20 | Astrazeneca Ab | Novel compounds |
SE0101322D0 (sv) | 2001-04-12 | 2001-04-12 | Astrazeneca Ab | Novel compounds |
GB0221828D0 (en) | 2002-09-20 | 2002-10-30 | Astrazeneca Ab | Novel compound |
GB0328243D0 (en) | 2003-12-05 | 2004-01-07 | Astrazeneca Ab | Methods |
EP2617424A3 (de) * | 2006-08-23 | 2014-05-07 | Government of the United States of America, as represented by the Secretary, Department of Health and Human Services | Harn- und Thioharnsäurederivate für Erkrankungen in Verbindung mit oxidativem Stress |
US9199945B2 (en) * | 2013-06-21 | 2015-12-01 | MyoKardia, Inc. | Cycloalkyl-substituted pyrimidinedione compounds |
ES2773250T3 (es) | 2013-06-21 | 2020-07-10 | Myokardia Inc | Compuestos de pirimidindiona contra afecciones cardíacas |
CN108912121A (zh) * | 2018-08-08 | 2018-11-30 | 南京纽邦生物科技有限公司 | 三种甲基尿酸类化合物的制备方法、中间体及中间体的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2781344A (en) * | 1953-05-04 | 1957-02-12 | Monsanto Chemicals | Formylation of amino-pyrimidines |
DE2329399A1 (de) * | 1973-06-08 | 1975-01-02 | Wuelfing J A Fa | 4-alkyl-aminouracile, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
US4452788A (en) * | 1982-04-21 | 1984-06-05 | Warner-Lambert Company | Substituted 8-phenylxanthines |
FR2531085A1 (fr) * | 1982-07-28 | 1984-02-03 | Adir | Nouveaux derives de la xanthine, leur procede de preparation et les compositions pharmaceutiques les renfermant |
-
1990
- 1990-03-15 FR FR909003342A patent/FR2659656B1/fr not_active Expired - Fee Related
-
1991
- 1991-03-13 CA CA002038198A patent/CA2038198A1/en not_active Abandoned
- 1991-03-14 DK DK91400699.4T patent/DK0447324T3/da active
- 1991-03-14 JP JP3049912A patent/JP2983669B2/ja not_active Expired - Lifetime
- 1991-03-14 ES ES91400699T patent/ES2081446T3/es not_active Expired - Lifetime
- 1991-03-14 EP EP91400699A patent/EP0447324B1/de not_active Expired - Lifetime
- 1991-03-14 AT AT91400699T patent/ATE131817T1/de not_active IP Right Cessation
- 1991-03-14 IE IE85391A patent/IE71192B1/en not_active IP Right Cessation
- 1991-03-14 PT PT97035A patent/PT97035B/pt not_active IP Right Cessation
- 1991-03-14 DE DE69115526T patent/DE69115526T2/de not_active Expired - Fee Related
-
1996
- 1996-02-28 GR GR960400547T patent/GR3019123T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
FR2659656B1 (fr) | 1994-09-09 |
PT97035B (pt) | 1998-07-31 |
ATE131817T1 (de) | 1996-01-15 |
DK0447324T3 (da) | 1996-04-29 |
DE69115526D1 (de) | 1996-02-01 |
EP0447324A1 (de) | 1991-09-18 |
CA2038198A1 (en) | 1991-09-16 |
IE910853A1 (en) | 1991-09-25 |
PT97035A (pt) | 1991-10-31 |
IE71192B1 (en) | 1997-02-12 |
ES2081446T3 (es) | 1996-03-16 |
GR3019123T3 (en) | 1996-05-31 |
EP0447324B1 (de) | 1995-12-20 |
JP2983669B2 (ja) | 1999-11-29 |
JPH04217672A (ja) | 1992-08-07 |
FR2659656A1 (fr) | 1991-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69115526T2 (de) | 2,4-Pyrimidindionderivate und diese enthaltende Arzneimittel | |
ATE170510T1 (de) | 3-(hydroxybenzylidenyl)-indolin-2-one und diese enthaltende arzneimittel | |
DE69627042T2 (de) | Isocumarinderivate und deren verwendung in medikamenten | |
ATE146186T1 (de) | Trifluormethylketon peptid derivate mit hle- inhibierende aktivität, deren herstellung und pharmazeutischen zusammensetzungen | |
ATE172975T1 (de) | Benzimidezolderivate mit antidiabetischer und anti-plättchenklumpungswirkung | |
NO179834C (no) | Substituerte cykloheksanderivater og anvendelse av forbindelsene for fremstilling av legemidler | |
NZ240575A (en) | N-benzoylproline derivatives and pharmaceutical compositions | |
ATE166875T1 (de) | Ellipticinderivate mit antitumorwirkung | |
DK0571243T3 (da) | Thiochromanderivater, fremgangsmåder til fremstilling heraf samt farmaceutiske midler indeholdende d isse | |
ES2095714T3 (es) | Nuevas amino-alquil-cromonas, sus procedimientos de preparacion y las composiciones farmaceuticas que las contienen. | |
DE69218205D1 (de) | 1,2,4-THIADIAZINO[3,4-b]BENZOTHIAZOL-DERIVATE, IHRE HERSTELLUNG UND SIE ENTHALTENDE ARZNEIMITTEL | |
ATE117682T1 (de) | Substituierte benzothiazolinone, ihre herstellung und sie enthaltende pharmazeutische zusammenstellungen. | |
ATE123770T1 (de) | 1,2,3,4-tetrahydronaphthylaminderivate mit nootroper aktivität und diese enthaltenden arzneimittel. | |
ATE201023T1 (de) | Ellipticinederivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: SANOFI-SYNTHELABO, PARIS, FR SOCIETE NATIONALE ELF |
|
8339 | Ceased/non-payment of the annual fee |